In Australia we have improved people?s wellbeing by delivering the highest quality medicines, vaccines and over-the-counter healthcare products since 1886. We provide about 1700 skilled jobs across the country, working with researchers and doctors to discover new ways of treating and preventing disease. In 2012 we invested $54 million a year in local research and development, and made significant contributions to Australia?s $4.2 billion pharmaceutical and medicinal exports.
The Boronia manufacturing plant is the largest GSK sterile facility globally. The site houses world leading blow-fill-seal technology, featuring eight filling machines and six packaging lines. The most recent edition is a second Relenza line completed in 2006.
The site has the capacity to produce 1.4 billion tablets per annum, including products for migraine, herpes, peptic ulcers, treatment of epilepsy, smoking cessation and anti-virals. Additional capsule products are manufactured for relief of asthma and pain management.
A microbiology laboratory is also located at the Boronia site that tests 4,000 samples each year and a chemistry laboratory that test 11,000 samples each year